GILD
$GILD
Gilead Sciences, Inc.
Biopharmaceutical company focused on HIV, hepatitis, and oncology.
Healthcare$131.27
+5.30 (+4.21%)
Day Range$126.46 - $131.58
Prev Close$125.97
Analyst Rating
Strong Buy
32 Buy / 7 Hold / 0 Sell
Subscribers
1
Tracking this ticker
Next Report
—
Weekly updates
Latest Report
This week's analysis
GILD: M&A, Yield and Growth Outlook ($GILD)
Gilead ($GILD) sits at a crossroads as recent asset deals and option flow point to renewed investor optimism. The stock offers income plus upside tied to product lifecycle and M&A execution.
Apr 6, 2026